Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far

References

• StuppRHegiMEMasonWPEffects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialLancet Oncol200910545946619269895
   PubMed Web of Science ®Google Scholar
• StuppRMasonWPvan den BentMJRadiotherapy plus concomitant and adjuvant temozolomide for glioblastomaN Engl J Med20053521098799615758009
   PubMed Web of Science ®Google Scholar
• de GrootJdaRBatchelorTTAntiangiogenic therapy for glioblastoma: the challenge of translating response rate into efficacyAm Soc Clin Oncol Educ Book201310.1200/EdBook_AM.2013.33.e71.
   PubMedGoogle Scholar
• BatchelorTTMulhollandPNeynsBPhase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastomaJ Clin Oncol Off J Am Soc Clin Oncol2013312632123218
   PubMed Web of Science ®Google Scholar
• KhasrawMAmeratungaMGrommesCBevacizumab for the treatment of high-grade glioma: an update after phase III trialsExpert Opin Biol Ther201414572974024655021
   PubMed Web of Science ®Google Scholar
• LentingKVerhaakRTer LaanMWesselingPLeendersWGlioma: experimental models and realityActa Neuropathologica2017133226328228074274
   PubMed Web of Science ®Google Scholar
• FolkmanJTumor angiogenesis: therapeutic implicationsN Engl J Med197128521118211864938153
   PubMed Web of Science ®Google Scholar
• DasSMarsdenPAAngiogenesis in glioblastomaN Engl J Med2013369161561156324131182
   PubMed Web of Science ®Google Scholar
• HardeeMEZagzagDMechanisms of glioma-associated neovascularizationAm J Pathol201218141126114122858156
   PubMed Web of Science ®Google Scholar
• PlateKHScholzADumontDJTumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisitedActa Neuropathologica2012124676377523143192
   PubMed Web of Science ®Google Scholar
• WangNJainRKBatchelorTTNew directions in anti-angiogenic therapy for glioblastomaNeurotherapeutics201714232133228083806
   PubMed Web of Science ®Google Scholar
• DimbergAThe glioblastoma vasculature as a target for cancer therapyBiochm Soc Trans201442616471652
   PubMedGoogle Scholar
• JainRKdi TomasoEDudaDGLoefflerJSSorensenAGBatchelorTTAngiogenesis in brain tumoursNat Rev Neurosci20078861062217643088
   PubMed Web of Science ®Google Scholar
• RaoNLeeYFGeRNovel endogenous angiogenesis inhibitors and their therapeutic potentialActa Pharmacol Sin201536101177119026364800
   PubMed Web of Science ®Google Scholar
• ChenFChenLHeHUp-regulation of microRNA-16 in glioblastoma inhibits the function of endothelial cells and tumor angiogenesis by targeting Bmi-1ACAMC2016165609620
   Google Scholar
• GagnerJ-PLawMFischerINewcombEWZagzagDAngiogenesis in gliomas: imaging and experimental therapeuticsBrain Pathology200515434236316389946
   PubMedGoogle Scholar
• RegeTAFearsCYGladsonCLEndogenous inhibitors of angiogenesis in malignant gliomas: nature’s antiangiogenic therapyNeuro-Oncol20057210612115831230
   PubMedGoogle Scholar
• NaborsLBFiveashJBMarkertJMA phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastomaArch Neurol201067331331920212229
   PubMedGoogle Scholar
• KongD-HKimMRJangJHNaH-JLeeSA review of anti-angiogenic targets for monoclonal antibody cancer therapyInt J Mol Sci2017188 pii: E1786
   Web of Science ®Google Scholar
• ChinotOLReardonDAThe future of antiangiogenic treatment in glioblastomaCurrent Opinion in Neurology201427667568225313693
   PubMed Web of Science ®Google Scholar
• GilbertMRSulmanEPMehtaMPBevacizumab for newly diagnosed glioblastomaN Engl J Med20143702120482049
   PubMed Web of Science ®Google Scholar
• CloughesyTFinocchiaroGBelda-IniestaCRandomized, double-blind, placebo-controlled, multicenter phase ii study of onartuzumab plus bevacizumab versus placebo plus bevacizumab in patients with recurrent glioblastoma: efficacy, safety, and hepatocyte growth factor and O6-methylguanine–DNA methyltransferase biomarker analysesJ Clin Oncol Off J Am Soc Clin Oncol2017353343351
   PubMed Web of Science ®Google Scholar
• GotinkKJVerheulHMWAnti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?Angiogenesis201013111420012482
   PubMed Web of Science ®Google Scholar
• PopescuAMPurcaruSOAlexandruODricuANew perspectives in glioblastoma antiangiogenic therapyWspółczesna Onkologia201622109118
   Google Scholar
• de GrootJFLambornKRChangSMPhase II study of aflibercept in recurrent malignant glioma: a North American brain tumor Consortium studyJ Clin Oncol Off J Am Soc Clin Oncol2011291926892695
   PubMed Web of Science ®Google Scholar
• ReardonDALassmanABSchiffDPhase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastomaCancer201812471438144829266174
   PubMed Web of Science ®Google Scholar
• WellerMNaborsLBGorliaTCilengitide in newly diagnosed glioblastoma: biomarker expression and outcomeOncotarget2016712150181503226918452
   PubMedGoogle Scholar
• JainRKNormalization of tumor vasculature: an emerging concept in antiangiogenic therapyScience20053075706586215637262
   PubMed Web of Science ®Google Scholar
• CalabreseCPoppletonHKocakMA perivascular niche for brain tumor stem cellsCancer Cell2007111698217222791
   PubMed Web of Science ®Google Scholar
• ChengLHuangZZhouWGlioblastoma stem cells generate vascular pericytes to support vessel function and tumor growthCell2013153113915223540695
   PubMed Web of Science ®Google Scholar
• FolkinsCManSXuPShakedYHicklinDJKerbelRSAnticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumorsCancer Res20076783560356417440065
   PubMed Web of Science ®Google Scholar
• de GrootJFPiaoYTranHMyeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with afliberceptClinical Cancer Research201117144872488121632852
   PubMed Web of Science ®Google Scholar
• ChenHXCleckJNAdverse effects of anticancer agents that target the VEGF pathwayNat Rev Clin Oncol20096846547719581909
   PubMed Web of Science ®Google Scholar
• JahangiriAChinATFlaniganPMChenRBankiewiczKAghiMKConvection-enhanced delivery in glioblastoma: a review of preclinical and clinical studiesJ Neurosurg20172693191200
   Google Scholar
• MehtaAMSonabendAMBruceJNConvection-enhanced deliveryNeurotherapeutics201714235837128299724
   PubMed Web of Science ®Google Scholar
• NdesendoVMConvection-enhanced delivery of neurotherapeuticsVinessPillay PChoonaraEPYAdvances in Neurotherapeutic Delivery Technologies8UKOMICS International2015
   Google Scholar
• VogelbaumMAAghiMKConvection-enhanced delivery for the treatment of glioblastomaNeuro-Oncology201517suppl 2ii3ii825746090
   PubMedGoogle Scholar
• WangWSivakumarWTorresSEffects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animalsNeurosurg Focus2015623E8
   Google Scholar
• OhlfestJRDemorestZLMotookaYCombinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping Beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastomaMolecular Therapy200512577878816150649
   PubMedGoogle Scholar
• GillespieDLAguirreMTRavichandranSRNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse modelJ Neurosurg2015122233134125423275
   PubMedGoogle Scholar
• HuangJYuanDLiuDEfficacy of antiangiogenic targeted immunotoxin DTAT and DTATEGF against glioblastoma multiformeZhong Nan Da Xue Xue Bao Yi Xue Ban20143911524473378
   PubMedGoogle Scholar
• GrossmanRTylerBHwangLImprovement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatinJ Neurosurg2011284611391146
   Google Scholar
• SchmidtNOZiuMCarrabbaGAntiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma modelClin Cancer Res20041041255126214977823
   PubMedGoogle Scholar
• ZagoracDJakovcevicDGebremedhinDHarderDRAntiangiogenic effect of inhibitors of cytochrome P450 on rats with glioblastoma multiformeJ Cereb Blood Flow Metab20082881431143918414496
   PubMed Web of Science ®Google Scholar
• ClavreulARogerEPourbaghi-MasoulehMLemaireLTétaudCMeneiPDevelopment and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastomaDrug Delivery20182511756176530338715
   PubMed Web of Science ®Google Scholar
• SampsonJHAkabaniGArcherGEIntracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumorsNeuro-Oncol200810332032918403491
   PubMed Web of Science ®Google Scholar
• ChewSADantiSBiomaterial-based implantable devices for cancer therapyAdv Healthcare Mater2017621600766
   Google Scholar
• WaitSDPrabhuRSBurriSHAtkinsTGAsherALPolymeric drug delivery for the treatment of glioblastomaNeuro-Oncology201517suppl 2ii9ii2325746091
   PubMedGoogle Scholar
• BasuADombAJRecent advances in polyanhydride based biomaterialsAdv Mater Deerfield Beach Fla20183041e1706815
   PubMedGoogle Scholar
• BotaDADesjardinsAQuinnJAAffrontiMLFriedmanHSInterstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomasTher Clin Risk Manag20073570771518472995
   PubMedGoogle Scholar
• BremHGabikianPBiodegradable polymer implants to treat brain tumorsJ Control Release2001741–3636711489483
   PubMed Web of Science ®Google Scholar
• TamargoRJMyserosJSEpsteinJIYangMBChasinMBremHInterstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brainCancer Res19935323293338417826
   PubMed Web of Science ®Google Scholar
• D’AvellaDDellapuppaASafety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastomasActa Neurochirurgica201215481379138122718139
   PubMedGoogle Scholar
• AshbyLSSmithKASteaBGliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature reviewWorld J Surg Onc2016141225
   PubMedGoogle Scholar
• BowHHwangLSSchildhausNLocal delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L gliomaJ Neurosurg2014114662669
   Google Scholar
• FrazierJLWangPPCaseDLocal delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial gliomaJ Neurooncol200364320320914558595
   PubMed Web of Science ®Google Scholar
• WeingartJDSiposEPBremHThe role of minocycline in the treatment of intracranial 9L gliomaJ Neurosurg1995484635640
   Google Scholar
• MartinsCSousaFAraújoFSarmentoBFunctionalizing PLGA and PLGA derivatives for drug delivery and tissue regeneration applicationsAdv Healthcare Mater2018711701035
   Google Scholar
• MirMAhmedNRehmanAURecent applications of PLGA based nanostructures in drug deliveryColloids and Surfaces B: Biointerfaces201715921723128797972
   PubMed Web of Science ®Google Scholar
• TsengY-YYangT-CWangY-CTargeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranesInt J Nanomedicine2017121265127628243088
   PubMed Web of Science ®Google Scholar
• HadjiargyrouMChiuJBEnhanced composite electrospun nanofiber scaffolds for use in drug deliveryExpert Opin Drug Deliv20085101093110618817515
   PubMed Web of Science ®Google Scholar
• TsengY-YWangY-CSuC-HConcurrent delivery of carmus-tine, irinotecan, and cisplatin to the cerebral cavity using biodegradable nanofibers: in vitro and in vivo studiesColloids and Surfaces B: Biointerfaces201513425426126209775
   PubMed Web of Science ®Google Scholar
• LeiCCuiYZhengLKah-Hoe ChowPWangC-HDevelopment of a gene/drug dual delivery system for brain tumor therapy: potent inhibition via RNA interference and synergistic effectsBiomaterials201334307483749423820014
   PubMed Web of Science ®Google Scholar
• TsengY-YSuC-HYangS-TAdvanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranesOncotarget2016737599025991627494894
   PubMedGoogle Scholar
• BennyOKimS-KGviliKIn vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma modelFaseb J200822248849917873103
   PubMedGoogle Scholar
• FloydJAGalperinARatnerBDDrug encapsulated polymeric microspheres for intracranial tumor therapy: a review of the literatureAdv Drug Deliv Rev201591233725895620
   PubMed Web of Science ®Google Scholar
• MeneiPCapelleLGuyotatJLocal and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trialNeurosurgery200556224224815670372
   PubMed Web of Science ®Google Scholar
• ChakrounRWZhangPLinRSchiapparelliPQuinones-HinojosaACuiHNanotherapeutic systems for local treatment of brain tumorsWiley Interdiscip Rev Nanomed Nanobiotechnol2018101e1479
   Google Scholar
• OngQHochbergFHCimaMJDepot delivery of dexamethasone and cediranib for the treatment of brain tumor associated edema in an intracranial rat glioma modelJ Controlled Release2015217183190
   PubMedGoogle Scholar
• GraysonACRChoiISTylerBMMulti-pulse drug delivery from a resorbable polymeric microchip deviceNat Mater200321176777214619935
   PubMed Web of Science ®Google Scholar
• KarimRPalazzoCEvrardBPielGNanocarriers for the treatment of glioblastoma multiforme: current state-of-the-artJ Control Release2016227233726892752
   PubMed Web of Science ®Google Scholar
• KumariPGhoshBBiswasSNanocarriers for cancer-targeted drug deliveryJ Drug Target201624317919126061298
   PubMed Web of Science ®Google Scholar
• NarayanaAApplications of nanotechnology in cancer: a literature review of imaging and treatmentJ Nucl Med Radiat Ther20140504195
   Google Scholar
• TanYFLaoLLXiongGMVenkatramanSControlled-release nanotherapeutics: state of translationJ Controlled Release20182843948
   PubMed Web of Science ®Google Scholar
• LiYLiJWooYMEnhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma modelBMC Cancer201717112628193190
   PubMedGoogle Scholar
• SonabendAMVelicuSUlasovIVA safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental gliomaAnti-Cancer Drugs200819213314218176109
   PubMedGoogle Scholar
• GasperiniLManoJFReisRLNatural polymers for the microencap-sulation of cellsJ R Soc Interface2014111002014081725232055
   PubMed Web of Science ®Google Scholar
• Gonzalez-PujanaASantosEOriveGPedrazJLHernandezRMCell microencapsulation technology: current vision of its therapeutic potential through the administration routesJ Drug Delivery Sci Technol2017424962
   Google Scholar
• OlabisiRMCell microencapsulation with synthetic polymersJ Biomed Mater Res20151032846859
   Google Scholar
• OparaECApplications of cell microencapsulationMethods Mol Biol Clifton NJ201714792339
   PubMedGoogle Scholar
• ShahKEncapsulated stem cells for cancer therapyBiomatter201331e2427823507920
   PubMedGoogle Scholar
• ReadT-ASorensenDRMahesparanRLocal endostatin treatment of gliomas administered by microencapsulated producer cellsNat Biotechnol2001191293411135548
   PubMedGoogle Scholar
• BjerkvigRReadTAVajkoczyPCell therapy using encapsulated cells producing endostatinActa Neurochir Suppl20038813714114531571
   PubMedGoogle Scholar
• ReadTAFarhadiMBjerkvigRIntravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cellsCancer Res200161186830683711559558
   PubMed Web of Science ®Google Scholar
• RogerMClavreulAVenier-JulienneM-CPassiraniCMontero-MeneiCMeneiPThe potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapyBiomaterials20113282106211621183214
   PubMed Web of Science ®Google Scholar
• ChoiSHTamuraKKhajuriaRKAntiangiogenic variant of TSP-1 targets tumor cells in glioblastomasMol Ther201523223524325358253
   PubMedGoogle Scholar
• de BoüardSGuillamoJ-SChristovCAntiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-alpha, angiostatin, or endostatinHum Gene Ther200314988389512828859
   PubMedGoogle Scholar
• EhteshamMKabosPKabosovaANeumanTBlackKLJsYThe use of interleukin 12-secreting neural stem cells for the treatment of intracranial gliomaCancer Res200262205657566312384520
   PubMed Web of Science ®Google Scholar
• KimS-KCargioliTGMachlufMPEX-producing human neural stem cells inhibit tumor growth in a mouse glioma modelClin Cancer Res200511165965597016115940
   PubMed Web of Science ®Google Scholar
• LoricoAMercapideJSoloduschkoVPrimary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastomaCancer Gene Ther200815960561518421309
   PubMed Web of Science ®Google Scholar
• RyuCHParkS-HParkSAGene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cellsHum Gene Ther201122673374321261460
   PubMed Web of Science ®Google Scholar
• van EekelenMSasportasLSKasmiehRHuman stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumorsOncogene201029223185319520305695
   PubMed Web of Science ®Google Scholar
• YangS-YLiuHZhangJ-NGene therapy of rat malignant gliomas using neural stem cells expressing IL-12DNA and Cell Biol200423638138915231071
   PubMedGoogle Scholar
• YinJKimJ-KMoonJ-HhMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrenceMol Ther20111961161116921386822
   PubMedGoogle Scholar
• ClavreulALautramNFranconiFMontaguALainéA-LTargeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsulesIJN2015101259127125709447
   PubMedGoogle Scholar
• ClavreulAPourbaghi-MasoulehMRogerELautramNMontero-MeneiCNMeneiPHuman mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?J Exp Clin Cancer Res201736113528962658
   PubMed Web of Science ®Google Scholar
• FischerUMHartingMTJimenezFPulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effectStem Cells Dev200918568369219099374
   PubMed Web of Science ®Google Scholar
• RamotYSteinerMMoradVPulmonary thrombosis in the mouse following intravenous administration of quantum dot-labeled mesenchymal cellsNanotoxicology2010419810520795905
   PubMed Web of Science ®Google Scholar
• GloverDJLippsHJJansDASafeTTowards safe, non-viral therapeutic gene expression in humansNat Rev Genet20056429931015761468
   PubMed Web of Science ®Google Scholar
• RidgeSMSullivanFJGlynnSAMesenchymal stem cells: key players in cancer progressionMol Cancer20171613128148268
   PubMed Web of Science ®Google Scholar
• ShermanLSShakerMMariottiVRameshwarPMesenchymal stromal/stem cells in drug therapy: new perspectiveCytotherapy2017191192727765601
   PubMedGoogle Scholar
• ShiYduLLinLWangYTumour-associated mesenchymal stem/stromal cells: emerging therapeutic targetsNat Rev Drug Discov2017161355227811929
   PubMed Web of Science ®Google Scholar
• ZhangCYangS-JWenQHuman-derived normal mesenchymal stem/stromal cells in anticancer therapiesJ Cancer201781859628123601
   PubMedGoogle Scholar
• BronckaersAHilkensPMartensWMesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesisPharmacol Ther2014143218119624594234
   PubMed Web of Science ®Google Scholar
• Merino-GonzálezCZuñigaFAEscuderoCMesenchymal stem cell-derived extracellular vesicles promote angiogenesis: Potencial clinical applicationFront Physiol20167992426903875
   PubMedGoogle Scholar
• RogerMClavreulASindjiLIn vitro and in vivo interactions between glioma and marrow-isolated adult multilineage inducible (Miami) cellsBrain Res2012147319320322819930
   PubMedGoogle Scholar
• ClavreulAEtcheverryATétaudCIdentification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical marginsJ Neurooncol2015122111025503303
   PubMedGoogle Scholar
• ClavreulAGuetteCFaguerRGlioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic propertiesJ Pathol20142331748824481573
   PubMedGoogle Scholar
• ClavreulAEtcheverryAChasseventAIsolation of a new cell population in the glioblastoma microenvironmentJ Neurooncol2012106349350421928115
   PubMedGoogle Scholar
• AppaixFNissouM-Fvan der SandenBBrain mesenchymal stem cells: The other stem cells of the brain?World J Stem Cells20146213414324772240
   PubMedGoogle Scholar
• HossainAGuminJGaoFMesenchymal stem cells isolated from human gliomas increase proliferation and maintain stemness of glioma stem cells through the IL-6/gp130/STAT3 pathwayStem Cells20153382400241525966666
   PubMedGoogle Scholar
• KongBHOShinH-DOKimSE-HIncreased in vivo angiogenic effect of glioma stromal mesenchymal stem-like cells on glioma cancer stem cells from patients with glioblastomaInt J Oncol20134251754176223483121
   PubMedGoogle Scholar
• LimE-JSuhYYooK-CTumor-associated mesenchymal stem-like cells provide extracellular signaling cue for invasiveness of glioblastoma cellsOncotarget2017811438144827903965
   PubMedGoogle Scholar
• SvenssonARamos-MorenoTEberstålSSchedingSBengzonJIdentification of two distinct mesenchymal stromal cell populations in human malignant gliomaJ Neurooncol2017131224525427757723
   PubMedGoogle Scholar
• ShaharTRozovskiUHessKRPercentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survivalNeuro Oncol201719566066828453745
   PubMed Web of Science ®Google Scholar
• YoonS-JShimJ-KChangJHTumor mesenchymal stem-like cell as a prognostic marker in primary glioblastomaStem Cells International20162016117
   Google Scholar
• ArgyriouAAGiannopoulouEKalofonosHPAngiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomasOncology200977111119439998
   PubMed Web of Science ®Google Scholar
• FerrariNGlodJLeeJKobilerDFineHAMarrow-DerivedBBone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectorsGene Ther200310864765612692593
   PubMed Web of Science ®Google Scholar
• NolanDJCiarrocchiAMellickASBone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularizationGenes Dev200721121546155817575055
   PubMed Web of Science ®Google Scholar
• PetersBADiazLAPolyakKContribution of bone marrow– derived endothelial cells to human tumor vasculatureNat Med200511326126215723071
   PubMedGoogle Scholar
• WongMLHPrawiraAKayeAHHovensCMTumour angiogenesis: its mechanism and therapeutic implications in malignant gliomasJ Clin Neurosci20091691119113019556134
   PubMed Web of Science ®Google Scholar
• SonaliViswanadhMKSinghRPNanotheranostics: emerging strategies for early diagnosis and therapy of brain cancerNanotheranostics201821708629291164
   PubMedGoogle Scholar